Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Breast 7Genitourinary 5Thoracic 4CNS 3Tumor-Agnostic 1Head & Neck 1

Conditions

Pain, Intractable 1Oropharyngeal Neoplasms 1Cancer Pain 1

Interventions

Radiotherapy 26Standard of Care 25Surveys and Questionnaires 22Blood Specimen Collection 21Cisplatin 20Radiotherapy, Intensity-Modulated 19Magnetic Resonance Spectroscopy 19Biopsy 15Practice Guidelines as Topic 13Low-Level Light Therapy 13Exercise 10X-Rays 9Surgical Procedures, Operative 9Radiosurgery 9Interviews as Topic 9Therapeutics 8Magnetic Resonance Imaging 8Saline Solution 7Radiofrequency Ablation 7Radiation 7Fluorodeoxyglucose F18 7Transcutaneous Electric Nerve Stimulation 6Thyroidectomy 6Immunohistochemistry 6Educational Status 6Control Groups 6Chemoradiotherapy 6Cetuximab 6Biopsy, Fine-Needle 6Acupuncture Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ropivacaine × Head & Neck × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡